Large molecule run acceptance: Recommendation for best practices and harmonization from the Global Bioanalysis...

Area of Science:

• Bioanalytical chemistry
• Pharmacokinetics
• Biopharmaceutical analysis

Background:

• Ligand binding assays are crucial for pharmacokinetic studies of macromolecules.
• Standardized methods are needed for reliable bioanalysis.
• Previous guidelines lacked specific recommendations for run acceptance criteria.

Purpose of the Study:

• To establish clear recommendations for run acceptance of ligand binding assays.
• To provide guidance on standard curve calibrators and quality controls.
• To define acceptance criteria for bioanalytical method validation and sample analysis.

Main Methods:

• The L1 Global Harmonization Team convened to review and synthesize best practices.
• Focus was placed on the preparation and acceptance criteria for standard curves and quality controls.
• Consideration was given to standard curve editing strategies and the concept of total error.

Main Results:

• Recommendations for standard curve calibrator and quality control acceptance were developed.
• Specific criteria for pre-study validation and in-study sample analysis were defined.
• Guidelines address preparation, acceptance, and editing of standard curves.

Conclusions:

• Implementing these recommendations will enhance the reliability of bioanalytical data.
• Standardized run acceptance criteria improve the consistency of pharmacokinetic studies.
• The guidelines aim to harmonize ligand binding assay practices globally.